Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label medications, and lifestyle strategies to manage involuntary movements.
Learn about dyskinesia, including its causes, symptoms, types, and available treatment options to help manage involuntary ...
Huntington’s disease can drain energy in many ways. Pacing yourself, eating enough, staying safely active, getting good sleep, and asking your care team about treatable symptoms can help.
Neurocrine Biosciences, Inc.  today announced the presentation of new data from a clinician survey highlighting the functional impact experienced by patients with mild tardive dyskinesia (TD) severity ...
Ingrezza (valbenazine) is a medication used to treat tardive dyskinesia (TD) and chorea associated with Huntington’s disease. These conditions cause involuntary movements like twitching, jerking, or ...
Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...
Cranial movement disorders are a common neurological problem. These disorders can be limited to the cranial muscles alone or manifest as part of a more generalized movement disorder. Cranial movement ...
New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood ...
New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood disorders, impacting their lives regardless of ageThe d ...
After losing the top spot in March to Johnson & Johnson’s immunology drug Tremfya, AbbVie’s rival med Skyrizi is back as the drug with the highest level of ad spending. | After losing the top spot in ...
Fetal movements refer to the muscular movements of the developing baby inside the mother's womb. These may be either reflex movements or elicited in response to noise or touch, at first. Before 9 ...